Two Sigma Securities’s Sunshine Biopharma SBFM Stock Holding History

Two Sigma Securities’s Portfolio SBFM Stock Details SBFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,348	Closed	-$24.4K	–	2275
2026 Q1	$24.4K	Buy	+2,348	New	+$27.7K	﹤0.01%	1344
2025 Q4	–	Sell	-1,718	Closed	-$25.6K	–	1942
2025 Q3	$25.6K	Buy	+1,718	New	+$25.5K	﹤0.01%	1090
2023 Q2	–	Sell	-1	Closed	-$18.5K	–	3273
2023 Q1	$18.5K	Buy	+1	New	+$18.2K	﹤0.01%	2374
2022 Q4	–	Sell	-1	Closed	-$13K	–	3178
2022 Q3	$13K	Hold	1	–	–	﹤0.01%	2362
2022 Q2	$22K	Hold	1	–	–	﹤0.01%	1945
2022 Q1	$32K	Buy	+1	New	+$48.7K	﹤0.01%	1926

Other funds holding SBFM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SFG

Strive Financial Group Carmel, Indiana $230M AUM

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Two Sigma Securities's SBFM Position: Q2 2026 in Review

Two Sigma Securities sold out of Sunshine Biopharma (SBFM) in Q2 2026, closing a stake of 2,348 shares — an estimated $24.4K sold.

Two Sigma Securities first reported a position in SBFM in Q1 2022 and held it in 6 quarters. The position peaked at $32K in Q1 2022. 9 funds tracked by Wall St. Rank hold SBFM as of Q2 2026.

Two Sigma Securities reported no remaining Sunshine Biopharma position as of Q2 2026 after selling out during the quarter.
Two Sigma Securities sold 2,348 Sunshine Biopharma shares in Q2 2026, an estimated $24.4K.
Two Sigma Securities first reported a position in Sunshine Biopharma in Q1 2022 and held it in 6 quarters.
Two Sigma Securities's Sunshine Biopharma position peaked at $32K in Q1 2022.
9 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.